The announcement of financial results is a critical event for any company, as it provides investors with insight into the company's performance and future prospects. For Akari Therapeutics, the FY23 financial results have led to a decrease in stock price, indicating that the results may not have met investor expectations. This reaction is typical in the stock market where financial performance directly influences investor sentiment and stock valuation.